$BXP

LABELLE MICHAEL E sold $1.7M of BXP

LABELLE MICHAEL E (EVP and CFO) sold 26,113 shares of BXP, Inc. (BXP) at an average of $66.35 ($66.05–$67.02, $1.73M total) across 2 trades on 2026-06-09.

Original reporting
SEC EDGAR · LABELLE MICHAEL E
Published Jun 10, 2026, 2:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 10, 2026, 2:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BXP
Neutral
medium confidence
Mentioned
$BXP
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BXPNeutralLow
01

Why it matters

Traders may monitor for follow-on insider activity or correlate with other upcoming company catalysts, but the disclosure alone does not change BXP’s operating outlook.

02

Market read

A CFO open-market sale totaling ~$1.73M is newly disclosed; it may slightly affect sentiment but lacks fundamental new information.

03

What to watch

The filing notes no pre-arranged 10b5-1 plan, which some traders may interpret as less “mechanical,” but the article provides no additional context (e.g., option exercises, tax planning) to confirm intent.

Relevance 6/10Novelty 6/10Timing: Filed June 10; sale executed June 9

Background

The article is an SEC Form 4 insider transaction disclosure for BXP, reporting sales by the EVP & CFO.

Company-level read

Ticker impact

$BXPNeutralMedium confidence
Context

BXP CFO sold 26,113 shares in open-market transactions totaling about $1.73M, disclosed via SEC Form 4 on June 10.

Expected impact

Low likelihood of a sustained price move; any reaction is likely short-lived unless paired with other company-specific catalysts.

Evidence & confidence

The filing is a primary-source insider transaction, but it does not include new fundamentals (earnings, guidance, deals, or regulatory actions). The absence of a stated 10b5-1 plan can add some interpretive noise, yet the disclosed value is not large enough to imply a major corporate event.

Market effects

Minimal—this is company-specific insider activity without sector-wide signal.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-existing personal liquidity needs rather than bearish expectations; the modest dollar amount supports that view.

Key entities

  • BXP, Inc.

    Real estate investment trust; subject of the Form 4 insider sale by its EVP & CFO.

  • LABELLE MICHAEL E

    EVP and CFO who sold 26,113 shares on June 9.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BXPLow

BXP, Inc. (BXP): Results of Operations and Financial Condition

BXP, Inc. (BXP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Supplemental Operating and Financial Data for the Quarter Ended September 30, 2026 THE COMPANY BXP, Inc. (NYSE: BXP) (“BXP” or the “Company”) is the largest publicly traded developer, owner, and manager of premier workplaces in the United States, concentrated in six

$IRMMed

Wall Street Analysts Are Bullish on Top Real Estate Picks

Analysts from Wells Fargo and other firms maintained Buy ratings on Iron Mountain (IRM), BXP, and Prologis (PLD) with price targets of $140, $82, and $150 respectively. IRM and PLD have Strong Buy consensus ratings, while BXP has a Moderate Buy rating. Average price targets suggest potential upsides of 31.4%, 24.3%, and 19.7% respectively.

$BXPMedAI 8/10

BXP sells equity stake in 343 Madison development

BXP sold a 10.6% equity stake in its $2B 343 Madison Ave. project to AVRS Partners, gaining financial flexibility. BXP secured a $1.2B construction loan with a SOFR+2.5% interest rate. Leasing progress includes Starr and McDermott Will & Schulte, with 70% pre-leased. Completion is expected in 2029.

$BXPMedAI 8/10

BXP Lands Equity Partner For Madison Avenue Office Project

BXP sold a 10.6% equity stake in its $2B Midtown Manhattan office tower project to AVRS Partners. The deal follows a $1.2B construction loan and provides BXP with financial flexibility. BXP retains control and management fees. AVRS, co-founded by Edmond Safra, has invested in other BXP properties, including the GM Building valued at $3.7B.